Investment banks compete for biotech business

11/13/2012 | Xconomy

JP Morgan, Bank of America/Merrill Lynch and Goldman Sachs are among the investment banks underwriting biotech companies this year, Securities and Exchange Commission filings show. Other investors include Needham & Co., BMO Capital Markets, Stifel Nicolaus and Oppenheimer. The financing of Regulus Therapeutics, which does not have a drug in clinical trials, shows that Wall Street may be willing to take more risks on biotech, Luke Timmerman writes.

View Full Article in:

Xconomy

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Actuary
Meridian Health Plan
Detroit, MI
Director, Payer Marketing
Avalere Health
Washington, DC
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Children's Health Plan
Houston, TX
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX